During the past decade, Cape Town Oncology Trials conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cape Town Oncology Trials" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Bayer" with 1 trials sponsored, "IO Biotech" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Zymeworks Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cape Town Oncology Trials" #1 collaborator was "BeiGene, Ltd." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Cape Town Oncology Trials" are "Malignant Melanoma" (3 trials), "Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials), "Esophageal Adenocarcinoma" (1 trials) and "Gastric Neoplasms" (1 trials). Many other conditions were trialed in "Cape Town Oncology Trials" in a lesser frequency.

Most popular intervention types in "Cape Town Oncology Trials" are "Drug" (12 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Atezolizumab" (2 trials), "Capecitabine" (2 trials), "Carboplatin" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cape Town Oncology Trials" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cape Town Oncology Trials". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Cape Town Oncology Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cape Town Oncology Trials, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".